Abstract
Despite the unsurpassed selectivity that enzymes usually offer,
biocatalytic transformations repeatedly fall short of the robustness and
process efficiency demanded for production-scale chemical synthesis.
Nucleotide sugar-dependent “Leloir” glycosyltransferases (GTs) are fine
catalysts of glycosylation but there is concern as to whether reactions
from this enzyme class are fit for industrial process development. We
demonstrate in this study of sucrose synthase (SuSy; EC 2.4.1.13) that,
in order to unlock the synthetic potential of the GT reaction, it was
vital to combine a focused, kinetic characteristics-based enzyme
selection with a reaction design properly aligned to thermodynamic
constraints. The equilibrium constant (Keq) for the conversion of sucrose and uridine 5′-diphosphate (UDP) into the target product UDP-α-d-glucose and d-fructose decreased with increasing pH due to deprotonation of the β-phosphate group of UDP above the pKa
of ∼6.0. Proton uptake coupled to the glucosyl transfer made it
essential that the pH was carefully controlled throughout the reaction.
Comparing two SuSys from Acidithiobacillus caldus and Glycine max
(soybean), substrate inhibition by UDP superseded catalytic efficiency
as the prior selection criterion, demanding choice of the bacterial GT
for use at high UDP concentrations. Reaction at the operational pH
optimum, determined as 5.0, gave 255 mM (144 g L−1) of UDP-glucose in 85% yield from UDP. Using an enzyme concentration of only 0.1 g L−1, a space-time yield of 25 g L−1 h−1
was obtained. The mass-based turnover number (g product formed per g
enzyme added) reached a value of 1440 from a single batch conversion.
Therefore, these parameters of the UDP-glucose synthesis show that the
reaction of a GT can be pushed to a process efficiency typically
required for implementation in fine chemicals production.
Original language | English |
---|---|
Pages (from-to) | 3600-3609 |
Journal | Advanced Synthesis & Catalysis |
Volume | 358 |
DOIs | |
Publication status | Published - 25 Oct 2016 |
Fields of Expertise
- Human- & Biotechnology
Treatment code (Nähere Zuordnung)
- Basic - Fundamental (Grundlagenforschung)